Payments to Acquire Property, Plant, and Equipment in USD of Lineage Cell Therapeutics, Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Lineage Cell Therapeutics, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and change rate from 2010 to Q1 2025.
  • Lineage Cell Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $97K, a 155% increase year-over-year.
  • Lineage Cell Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $565K, a 16.2% decline from 2023.
  • Lineage Cell Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $674K, a 63.2% increase from 2022.
  • Lineage Cell Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $413K, a 21.5% increase from 2021.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Lineage Cell Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $97K +$59K +155% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q1 2024 $38K -$150K -79.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q1 2023 $188K +$142K +309% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $46K +$35K +318% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $11K +$1K +10% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-13
Q1 2020 $10K -$159K -94.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $169K -$29K -14.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 $198K -$17K -7.91% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2017 $215K -$368K -63.1% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $583K +$506K +657% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q1 2015 $77K -$155K -66.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q1 2014 $232K -$264K -53.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q1 2013 $496K +$380K +325% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2012 $117K -$179K -60.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 $296K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10

Lineage Cell Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $565K -$109K -16.2% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-10
2023 $674K +$261K +63.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-10
2022 $413K +$73K +21.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $340K +$276K +431% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $64K -$376K -85.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $440K -$116K -20.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $556K -$770K -58.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $1.33M -$922K -41% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-14
2016 $2.25M +$1.01M +81.1% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $1.24M +$758K +157% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 $483K -$1.79M -78.8% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $2.28M +$1.88M +468% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $401K -$559K -58.3% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-11
2011 $960K +$740K +335% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-17
2010 $221K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.